T cell help in human antigen‐specific antibody responses can be replaced by interleukin 2
- 1 January 1986
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 16 (9), 1037-1042
- https://doi.org/10.1002/eji.1830160902
Abstract
Recombinant IL2, and immunosorbent/high performance liquid chromatography‐purified interleukin 2 (IL2) obtained from the human T cell leukemic line Jurkat, but not interferon‐α or ‐γ, were able to substitute for T cells in specific antibody responses to influenza virus by T cell‐depleted (E−) human peripheral blood mononuclear cells, and resulted in antibody formation equivalent to that obtained in the presence of T cells. The antibody response was shown to be antigen specific by using two non‐cross‐reacting strains of influenza virus (A/X31 and B/HK). IL2 in this assay therefore functions as a T cell‐replacing factor. Less than 1 % of T (UCHT1+) cells were present in the E− preparations, and this number did not increase during the 7‐day culture with antigen and IL2. Because the frequency of T helper cells for X31 is known to be less than 5 ± 10−5, this low number of contaminating cells excluded indirect action of IL2 through antigen‐specific T helper cells. Three to four times less IL2 was required for antibody production by E− cells than was needed for optimal proliferation by an IL2‐ dependent T cell line. Moreover, the concentration of anti‐Tac required for 50% inhibition of the IL 2‐induced antibody response was 50 times less than required for 50% inhibition of IL2‐dependent proliferation by the T cell line. But when T cells were added back to the E− cells, the anti‐Tac inhibition curve shifted back to that obtained with the T cell line. In cell labeling experiments, Leu11+ cells but not HNK1+ cells were increased in E− cells cultured with antigen and IL2. This increase in Leu 11+ cells was abolished by prior passage of the E− cells through Sephadex G‐10 columns without affecting the IL2‐induced antibody response. From these experiments we conclude that IL2 can replace T cells in specific antibody responses, and that the IL 2 effect is not mediated indirectly through T cells or large granular lymphocytes.This publication has 30 references indexed in Scilit:
- Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity.The Journal of Experimental Medicine, 1986
- T cell‐replacing factor in specific antibody responses to influenza virus by human blood B cellsEuropean Journal of Immunology, 1985
- Antigen-nonspecific T cell-derived factors in B cell activation: differences in the requirements for interleukin 2 in responses of unprimed and primed B cellsEuropean Journal of Immunology, 1985
- Human clones with natural killer function can activate B cells and secrete B cell differentiation factorsEuropean Journal of Immunology, 1984
- Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cellsNature, 1984
- Interleukin 2: the molecule and its functionImmunology Today, 1984
- Antigen specificity and frequency of autologous and allogeneic helper T cells in the in vitro production of antibody against influenza virus by human blood lymphocytesEuropean Journal of Immunology, 1981
- Distinctive functional characteristics of human „T”︁ lymphocytes defined by E rosetting or a monoclonal anti‐T cell antibodyEuropean Journal of Immunology, 1981
- Histocompatibility requirements for T cell help in specific in vitro antibody responses to influenza virus by human blood lymphocytesEuropean Journal of Immunology, 1981
- Specific in vitro antibody response to influenza virus by human blood lymphocytesNature, 1979